Amarin Pharma, Inc.

Amarin Pharma, Inc. reported a data breach involving a third-party vendor's database containing consumer information for its Vascepa copay program. The breach resulted from a database misconfiguration allowing unauthorized access between May 2, 2018, and June 20, 2019. Affected data included names, addresses, phone numbers, and medication interest data. No financial or SSN data was involved. Amarin suspended data feeds and took the database offline, engaging forensic investigators.